West Pharmaceutical Services (WST) P/E ratio

P/E ratio today
46.5×

West Pharmaceutical Services (WST) trades at 46.5× its earnings per share over the last twelve months. At the end of fiscal 2025 (December 31, 2025) its P/E ratio was 40.5×. That is 17.2% lower than the 49.0× of fiscal 2024. Figures as of 18 Nov 2026, 06:37 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

P/E ratio today
46.5×
P/E ratio, fiscal 2025
40.5×
Change on fiscal 2024
−17.2%
Highest on record
62.0×fiscal 2020
Lowest on record
15.1×fiscal 2008
Fiscal years on record
182008–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

West Pharmaceutical Services P/E ratio, in more detail

Today's figure is 14.7% above the fiscal 2025 year-end.

Across the 18 fiscal year-ends on record (2008–2025), the highest was 62.0× in fiscal 2020 and the lowest 15.1× in fiscal 2008. Today's P/E ratio is higher than at 72% of the 18 fiscal year-ends on record; their median is 38.1×.

History · 18 fiscal years

P/E ratio at each fiscal year-end

The last point is today's figure; the others are fiscal year-ends.

West Pharmaceutical Services P/E ratio, year by year

West Pharmaceutical Services (WST) P/E ratio by fiscal year
Fiscal yearP/E ratioChangeYear endedShare price at year-endDiluted EPS
Today46.5×—$414.12—
202540.5× 17.2% down$275.14$6.79
202449.0× 9.6% up$327.56$6.69
202344.7× 46.8% up$352.12$7.88
202230.4× 43.7% down$235.35$7.73
202154.1× 12.7% down$469.01$8.67
202062.0× 32.4% up$283.31$4.57
201946.8× 30.9% up$150.33$3.21
201835.8× 27.8% down$98.03$2.74
201749.6× 11.6% up$98.67$1.99
201644.4× 4.1% down$84.83$1.91
201546.3× 52.3% up$60.22$1.30
201430.4× 2.6% down$53.24$1.75
201331.2× 31.3% up$49.06$1.57
201223.8× 35.5% up$27.38$1.15
201117.6× 19.4% down$18.98$1.08
201021.8× 17.9% up$20.60$0.95
200918.5× 22.4% up$19.60$1.06
200815.1×—$18.89$1.25

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The P/E ratio is the share price divided by earnings per share: for past years this page divides the closing price for the month each fiscal year ended in by that year's diluted earnings per share, and a year with a loss has no P/E.

How to read it

It is the number of years of current profit the price pays for — a high figure means investors expect growth, and it is best judged against the company's own history.

P/E ratio at health care companies of similar size

P/E ratio of West Pharmaceutical Services and comparable companies
CompanyP/E ratio
Labcorp Holdings LH30.2×
DexCom DXCM32.3×
Koninklijke Philips PHG26.0×
West Pharmaceutical Services WST46.5×
Quest Diagnostics DGX25.5×

Price over the last twelve months' earnings per share, as the market data feed reports it.

More on WST

West Pharmaceutical Services, figure by figure

West Pharmaceutical Services (WST) overview: price, valuation and scorecardAll health care companies by market value

West Pharmaceutical Services P/E ratio: questions and answers

What is West Pharmaceutical Services's P/E ratio?

West Pharmaceutical Services (WST) trades at 46.5× its earnings per share over the last twelve months. At the end of fiscal 2025 (December 31, 2025) its P/E ratio was 40.5×. That is 17.2% lower than the 49.0× of fiscal 2024.

Is West Pharmaceutical Services's P/E ratio high or low compared with its own history?

Today's P/E ratio is higher than at 72% of the 18 fiscal year-ends on record; their median is 38.1×.

What are the highest and lowest P/E ratio figures on record for West Pharmaceutical Services?

Across the 18 fiscal year-ends on record (2008–2025), the highest was 62.0× in fiscal 2020 and the lowest 15.1× in fiscal 2008.

How is West Pharmaceutical Services's P/E ratio calculated?

The P/E ratio is the share price divided by earnings per share: for past years this page divides the closing price for the month each fiscal year ended in by that year's diluted earnings per share, and a year with a loss has no P/E.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “West Pharmaceutical Services (WST) P/E ratio”, data as of 18 November 2026. https://funkfolio.com/stock/WST/pe-ratio

Underlying data: the company's filings with the SEC and Yahoo Finance.